Page 147 - Read Online

Page 13 of 13 Alsulihem et al. Neuroimmunol Neuroinflammation 2019;6:13 I http://dx.doi.org/10.20517/2347-8659.2019.007

urinary tract dysfunction. J Urol 1999;161:1803-6.
56. Tan HJ, Stoffel J, Daignault S, McGuire EJ, Latini JM. Ileovesicostomy for adults with neurogenic bladders: complications and
potential risk factors for adverse outcomes. Neurourol Urodyn 2008;27:238-43.
57. Ginsberg D. The epidemiology and pathophysiology of neurogenic bladder. Am J Manag Care 2013;19:s191-6.
58. Myers JB, Lenherr SM, Stoffel JT, Elliott SP, Presson AP, et al; Neurogenic Bladder Research Group. Patient reported bladder related
symptoms and quality of life after spinal cord injury with different bladder management strategies. J Urol 2019;202:574-84.
59. Adriaansen JJ, van Asbeck FW, Tepper M, Faber WX, Visser-Meily JM, et al. Bladder-emptying methods, neurogenic lower urinary
tract dysfunction and impact on quality of life in people with long-term spinal cord injury. J Spinal Cord Med 2017;40:43-53.
60. Gamé X, Peyronnet B, Cornu JN. Fesoterodine: pharmacological properties and clinical implications. Eur J Pharmacol 2018;833:155-7.